Bupropion for the Treatment of Methamphetamine Dependence - 1

NCT00069251 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

NIH

Sponsor class

Conditions

Amphetamine-Related Disorders

Interventions

DRUG: Bupropion

Sponsor

National Institute on Drug Abuse (NIDA)